Developments in neuro-oncology

被引：0
作者：
Silvia Hofer
机构：
[1] Luzerner Kantonsspital,Division of Medical Oncology
来源：
memo - Magazine of European Medical Oncology | 2018年 / 11卷 / 2期
关键词：
World Health Organization Classification of Tumors of the Central Nervous System; Glioma; Histology; Molecular Marker; Treatment;
D O I：
10.1007/s12254-016-0278-0
中图分类号：
学科分类号：
摘要：
A short statement on the most recent developments in the neuro-oncology field, including the new WHO Classification of Tumors of the Central Nervous System (2016) and current treatment strategies.
引用
收藏
页码：161 / 162
页数：1
相关论文
共 22 条
[1]  
Louis DN(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820
[2]  
Perry A(2016)Pharmacotherapies for the treatment of glioblastoma – current evidence and perspectives Expert Opin Pharmacother 17 1259-1270
[3]  
Reifenberger G(2016)PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma Oncotarget 374 1344-1355
[4]  
Seystahl K(2016)Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma N Engl J Med 32 783-790
[5]  
Gramatzki D(2014)Benefit from procarbazine, lomus-tine, and vincristine in oligodendroglial tumors is associated with mutation of IDH J Clin Oncol 31 344-350
[6]  
Roth P(2013)Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 J Clin Oncol 74 867-872
[7]  
Weller M(2015)BRAF fusion analysis in pilocytic astrocytomas: KIAA1549-BRAF 15-9 fusions are more frequent in the midline than within the cerebellum J Neuropathol Exp Neurol undefined undefined-undefined
[8]  
Li X(undefined)undefined undefined undefined undefined-undefined
[9]  
Wu C(undefined)undefined undefined undefined undefined-undefined
[10]  
Chen N(undefined)undefined undefined undefined undefined-undefined
123